Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis - Concepedia

Concepedia

Publication | Open Access

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

DOI Full Paper Access

67

Citations

27

References

2019

Year

David M. Faleck, Adam C. Winters, Shreya Chablaney, Preeti Shashi, Joseph Meserve, Aaron Weiss, Satimai Aniwan, Jenna L. Koliani‐Pace, Gursimran Kochhar, Brigid S. Boland,

Clinical Gastroenterology and Hepatology

References

	Year	Citations

Page 1